MX2009012990A - Proceso para proporcionar un relajante muscular estable a la temperatura sobre la base del componente neurotoxico de toxina botulinica. - Google Patents
Proceso para proporcionar un relajante muscular estable a la temperatura sobre la base del componente neurotoxico de toxina botulinica.Info
- Publication number
- MX2009012990A MX2009012990A MX2009012990A MX2009012990A MX2009012990A MX 2009012990 A MX2009012990 A MX 2009012990A MX 2009012990 A MX2009012990 A MX 2009012990A MX 2009012990 A MX2009012990 A MX 2009012990A MX 2009012990 A MX2009012990 A MX 2009012990A
- Authority
- MX
- Mexico
- Prior art keywords
- muscle relaxant
- providing
- stable
- botulinum toxin
- basis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La presente invenci?n proporciona un proceso para proporcionar un relajante muscular, donde el relajante muscular es una soluci?n reconstituida que comprende un componente neurot?xico de toxina botul?nica libre de prote?nas complejantes, que exhibe al menos una de las siguientes caracter?sticas, de manera m?s preferible todas las caracter?sticas a) a d): a) Estable a temperaturas de almacenamiento superiores a 20?C; b) estable en presencia de preservativos y/o analg?sico; c) resistente contra ciclos de "congelamiento y descongelamiento"; d) estable si se almacena en recipientes de diferente material.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93262407P | 2007-06-01 | 2007-06-01 | |
EP07010912A EP1997509A1 (en) | 2007-06-01 | 2007-06-01 | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
US99885807P | 2007-10-12 | 2007-10-12 | |
EP07020025A EP2048156A1 (en) | 2007-10-12 | 2007-10-12 | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
PCT/EP2008/004254 WO2008145359A1 (en) | 2007-06-01 | 2008-05-28 | Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009012990A true MX2009012990A (es) | 2010-04-01 |
Family
ID=40074591
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009012570A MX2009012570A (es) | 2007-06-01 | 2008-05-28 | Proceso para proveer un relajante muscular estable a la temperatura a base del componente neurotoxico de la toxina botulinica en forma solida. |
MX2009012990A MX2009012990A (es) | 2007-06-01 | 2008-05-28 | Proceso para proporcionar un relajante muscular estable a la temperatura sobre la base del componente neurotoxico de toxina botulinica. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009012570A MX2009012570A (es) | 2007-06-01 | 2008-05-28 | Proceso para proveer un relajante muscular estable a la temperatura a base del componente neurotoxico de la toxina botulinica en forma solida. |
Country Status (15)
Country | Link |
---|---|
US (2) | US20090010965A1 (es) |
EP (2) | EP2170375A1 (es) |
JP (2) | JP2010529000A (es) |
KR (2) | KR20100020972A (es) |
CN (2) | CN101687018A (es) |
AR (2) | AR066783A1 (es) |
AU (2) | AU2008256419A1 (es) |
BR (2) | BRPI0812245A2 (es) |
CA (2) | CA2686637A1 (es) |
IL (2) | IL202129A0 (es) |
MX (2) | MX2009012570A (es) |
RU (1) | RU2009149604A (es) |
TW (2) | TW200902050A (es) |
WO (2) | WO2008145358A1 (es) |
ZA (2) | ZA200907874B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8168206B1 (en) | 2005-10-06 | 2012-05-01 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
AR061669A1 (es) | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
US10792344B2 (en) | 2006-06-29 | 2020-10-06 | Merz Pharma Gmbh & Co. Kgaa | High frequency application of botulinum toxin therapy |
RU2011125775A (ru) | 2008-12-31 | 2013-02-10 | Реванс Терапьютикс, Инк. | Составы на основе ботулотоксина для инъекции |
US20100184685A1 (en) * | 2009-01-19 | 2010-07-22 | Zavala Jr Gerardo | Systems and methods for treating post- operative, acute, and chronic pain using an intra-muscular catheter administrated combination of a local anesthetic and a neurotoxin protein |
WO2010094463A1 (en) * | 2009-02-19 | 2010-08-26 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for manufacturing highly pure neurotoxin |
EP2248518B1 (en) * | 2009-04-17 | 2013-01-16 | Merz Pharma GmbH & Co. KGaA | Formulation for stabilizing proteins, peptides or mixtures thereof. |
CA2757637C (en) * | 2009-04-27 | 2017-10-24 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities |
KR102328155B1 (ko) | 2009-06-25 | 2021-11-17 | 레반스 테라퓨틱스, 아이엔씨. | 알부민불포함 보툴리눔 독소 제제 |
MX2012004703A (es) * | 2009-10-21 | 2012-06-08 | Revance Therapeutics Inc | Metodos y sistemas para purificar la neurotoxina botulinica no acomplejada. |
SG10201605324PA (en) * | 2011-03-31 | 2016-08-30 | Medy Tox Inc | Lyophilized preparation of botulinum toxin |
KR101135486B1 (ko) * | 2011-05-25 | 2012-04-13 | 함종욱 | 보툴리눔 에이형 독소의 액상제품 |
KR101357999B1 (ko) * | 2012-03-20 | 2014-02-03 | 함종욱 | 보툴리눔 에이형 독소의 액상제품 |
EP3236939B1 (en) * | 2014-12-23 | 2020-04-01 | Merz Pharma GmbH & Co. KGaA | Botulinum toxin prefilled container |
US10406290B2 (en) | 2015-02-03 | 2019-09-10 | Merz Pharma Gmbh & Co. Kgaa | Botulinum toxin prefilled plastic syringe |
EP3070539A1 (fr) * | 2015-03-17 | 2016-09-21 | Omega SA | Montre-bracelet comprenant un cadran muni d'index lumineux |
WO2018038301A1 (en) * | 2016-08-26 | 2018-03-01 | Hugel Inc. | Stabilized liquid formulation of botulinum toxin and preparation method thereof |
MX2020014330A (es) * | 2018-12-26 | 2021-03-09 | Caregen Co Ltd | Composicion para relajacion muscular. |
WO2020138674A1 (ko) | 2018-12-26 | 2020-07-02 | (주)케어젠 | 근육 이완용 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756468A (en) * | 1994-10-13 | 1998-05-26 | Wisconsin Alumni Research Foundation | Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
TW574036B (en) * | 1998-09-11 | 2004-02-01 | Elan Pharm Inc | Stable liquid compositions of botulinum toxin |
DE19925739A1 (de) * | 1999-06-07 | 2000-12-21 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum mit einem Botulinum-Neurotoxin |
US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
US20030224020A1 (en) * | 2002-05-31 | 2003-12-04 | Zabudkin Alexander F. | Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use |
CN101005853B (zh) * | 2004-07-26 | 2011-05-04 | 莫茨药物股份两合公司 | 包含肉毒杆菌神经毒素的治疗组合物 |
DE102004043009A1 (de) | 2004-09-06 | 2006-03-23 | Toxogen Gmbh | Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen |
DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
CA2612205C (en) * | 2005-06-17 | 2012-07-10 | Merz Pharma Gmbh & Co. Kgaa | Apparatus and process for the fermentative production of biological active compounds |
US8323666B2 (en) * | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
AR061669A1 (es) * | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
-
2008
- 2008-05-28 CN CN200880018442A patent/CN101687018A/zh active Pending
- 2008-05-28 WO PCT/EP2008/004253 patent/WO2008145358A1/en active Application Filing
- 2008-05-28 MX MX2009012570A patent/MX2009012570A/es not_active Application Discontinuation
- 2008-05-28 BR BRPI0812245-8A2A patent/BRPI0812245A2/pt not_active IP Right Cessation
- 2008-05-28 EP EP08758836A patent/EP2170375A1/en not_active Withdrawn
- 2008-05-28 JP JP2010509731A patent/JP2010529000A/ja active Pending
- 2008-05-28 RU RU2009149604/15A patent/RU2009149604A/ru not_active Application Discontinuation
- 2008-05-28 KR KR1020097026300A patent/KR20100020972A/ko not_active Application Discontinuation
- 2008-05-28 AU AU2008256419A patent/AU2008256419A1/en not_active Abandoned
- 2008-05-28 AU AU2008256418A patent/AU2008256418A1/en not_active Abandoned
- 2008-05-28 BR BRPI0812322-5A2A patent/BRPI0812322A2/pt not_active IP Right Cessation
- 2008-05-28 MX MX2009012990A patent/MX2009012990A/es not_active Application Discontinuation
- 2008-05-28 KR KR1020097026298A patent/KR20100020971A/ko not_active Application Discontinuation
- 2008-05-28 WO PCT/EP2008/004254 patent/WO2008145359A1/en active Application Filing
- 2008-05-28 CN CN200880018452A patent/CN101720331A/zh active Pending
- 2008-05-28 EP EP08758837A patent/EP2164861A1/en not_active Withdrawn
- 2008-05-28 JP JP2010509730A patent/JP2010528999A/ja active Pending
- 2008-05-28 CA CA002686637A patent/CA2686637A1/en not_active Abandoned
- 2008-05-28 CA CA002686642A patent/CA2686642A1/en not_active Abandoned
- 2008-05-29 US US12/154,982 patent/US20090010965A1/en not_active Abandoned
- 2008-05-29 US US12/154,983 patent/US20090028906A1/en not_active Abandoned
- 2008-05-30 TW TW097120348A patent/TW200902050A/zh unknown
- 2008-05-30 AR ARP080102287A patent/AR066783A1/es not_active Application Discontinuation
- 2008-05-30 AR ARP080102286A patent/AR066782A1/es not_active Application Discontinuation
- 2008-05-30 TW TW097120349A patent/TW200914039A/zh unknown
-
2009
- 2009-11-10 ZA ZA2009/07874A patent/ZA200907874B/en unknown
- 2009-11-10 ZA ZA2009/07875A patent/ZA200907875B/en unknown
- 2009-11-15 IL IL202129A patent/IL202129A0/en unknown
- 2009-11-15 IL IL202130A patent/IL202130A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101687018A (zh) | 2010-03-31 |
AU2008256419A1 (en) | 2008-12-04 |
CN101720331A (zh) | 2010-06-02 |
TW200902050A (en) | 2009-01-16 |
AU2008256418A1 (en) | 2008-12-04 |
US20090028906A1 (en) | 2009-01-29 |
MX2009012570A (es) | 2010-03-15 |
JP2010529000A (ja) | 2010-08-26 |
BRPI0812322A2 (pt) | 2014-11-25 |
CA2686642A1 (en) | 2008-12-04 |
ZA200907874B (en) | 2011-03-30 |
RU2009149604A (ru) | 2011-07-20 |
EP2170375A1 (en) | 2010-04-07 |
TW200914039A (en) | 2009-04-01 |
WO2008145358A1 (en) | 2008-12-04 |
US20090010965A1 (en) | 2009-01-08 |
AR066783A1 (es) | 2009-09-09 |
BRPI0812245A2 (pt) | 2014-10-21 |
IL202130A0 (en) | 2010-06-16 |
KR20100020971A (ko) | 2010-02-23 |
EP2164861A1 (en) | 2010-03-24 |
WO2008145359A1 (en) | 2008-12-04 |
KR20100020972A (ko) | 2010-02-23 |
ZA200907875B (en) | 2010-11-24 |
AR066782A1 (es) | 2009-09-09 |
CA2686637A1 (en) | 2008-12-04 |
IL202129A0 (en) | 2010-06-16 |
JP2010528999A (ja) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012990A (es) | Proceso para proporcionar un relajante muscular estable a la temperatura sobre la base del componente neurotoxico de toxina botulinica. | |
EP1928226A4 (en) | TOLERANCE OF PLANTS WITH STRESS | |
MY162136A (en) | Activin-actrii antagonists and uses for treating anemia | |
WO2006134190A3 (es) | Agentes y métodos basados en el uso del dominio eda de la fibronectina | |
MX360211B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
WO2008006422A3 (de) | Verwendung von ionischen flüssigkeiten oder lösungen aus metallsalzen in ionischen flüssigkeiten als antistatika für kunststoffe | |
WO2011060206A3 (en) | Material and methods for treating or preventing her-3 associated diseases | |
WO2009126292A3 (en) | Biologically active peptidomimetic macrocycles | |
WO2007140002A3 (en) | Method for treating non-hodgkin's lymphoma | |
WO2008069889A3 (en) | Methods of treating hemolytic anemia | |
WO2008143666A3 (en) | Crystal structures of neuropilin fragments and neuropilin-antibody complexes | |
WO2007120651A3 (en) | Uses and compositions for treatment of juvenile rheumatoid arthritis | |
WO2006015297A3 (en) | Methods of treating type i diabetes by blocking vegf-mediated activity | |
WO2008127355A3 (en) | Chemorepulsion of cells | |
WO2008085229A3 (en) | Cell-based therapies for treating liver disease | |
ATE554122T1 (de) | Polymere mit kondensiertem selenophen | |
NZ603196A (en) | Methods of use of soluble cd24 for therapy of rheumatoid arthritis | |
BRPI0508084A (pt) | método para o tratamento de um distúrbio neurológico, e, uso de meridamicina ou um sal do mesmo | |
WO2006135493A3 (en) | A composition for wound healing and use thereof | |
WO2011056954A8 (en) | Haemophilus parasuis polypeptides and methods of use | |
CA3010564A1 (en) | An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition | |
WO2009046015A3 (en) | Combination therapies for treating type 1 diabetes | |
UA94231C2 (ru) | Олигонуклеотиды или их функциональные гомологи, композиция, которая содержит их, и способ лечения в-клеточной опухоли | |
MX2007011381A (es) | Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion. | |
NZ589365A (en) | Peptidyl diacylglycerides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |